ストックスクリーナーアプリを入手
89.81
2.09%
1.875
前日終値:
$87.94
開ける：
$87.64
24時間の取引高:
1.12M
Relative Volume:
0.18
時価総額：
$112.85B
収益：
$33.20B
当期純損益:
$4.26B
株価収益率:
27.30
EPS:
3.29
ネットキャッシュフロー:
$5.47B
1週間 パフォーマンス:
-3.26%
1か月 パフォーマンス:
+1.58%
6か月 パフォーマンス:
+2.56%
1年 パフォーマンス:
+4.52%
1日の値動き範囲:
$87.58
$89.89
1週間の範囲:
$85.06
$89.83
52週間の値動き範囲:
$75.96
$93.08
Medtronic Plc Stock (MDT) Company Profile
名前
Medtronic Plc
セクター
電話
01135314381700
住所
BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY
MDT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MDT
Medtronic Plc
|
89.87 | 112.85B | 33.20B | 4.26B | 5.47B | 3.29 |
|
ABT
Abbott Laboratories
|
133.94 | 230.98B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
105.25 | 155.49B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
384.96 | 147.45B | 22.60B | 2.99B | 3.49B | 7.76 |
|
EW
Edwards Lifesciences Corp
|
74.00 | 44.06B | 5.72B | 4.17B | 490.10M | 6.97 |
Medtronic Plc Stock (MDT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-10-10 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-08-21 | 繰り返されました | Oppenheimer | Perform |
| 2024-08-15 | アップグレード | UBS | Sell → Neutral |
| 2024-08-14 | ダウングレード | Stifel | Buy → Hold |
| 2024-05-30 | 開始されました | Goldman | Sell |
| 2023-07-19 | 開始されました | Robert W. Baird | Neutral |
| 2023-06-30 | 開始されました | CL King | Buy |
| 2023-05-30 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-24 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2023-03-29 | ダウングレード | UBS | Buy → Sell |
| 2023-01-09 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-11-23 | ダウングレード | Citigroup | Buy → Neutral |
| 2022-11-23 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2022-11-16 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2022-10-18 | 開始されました | Barclays | Equal Weight |
| 2022-10-13 | 開始されました | Mizuho | Buy |
| 2022-10-12 | 開始されました | Jefferies | Hold |
| 2022-08-24 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2022-07-06 | 開始されました | Wolfe Research | Underperform |
| 2022-06-01 | ダウングレード | Atlantic Equities | Overweight → Neutral |
| 2022-05-27 | ダウングレード | Needham | Buy → Hold |
| 2022-04-13 | ダウングレード | Truist | Buy → Hold |
| 2022-03-02 | 再開されました | BofA Securities | Buy |
| 2022-01-10 | ダウングレード | BTIG Research | Buy → Neutral |
| 2022-01-07 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2021-12-17 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2021-12-16 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2021-12-10 | 開始されました | RBC Capital Mkts | Outperform |
| 2021-06-10 | 再開されました | Cowen | Outperform |
| 2021-05-25 | 開始されました | Barclays | Equal Weight |
| 2021-04-15 | 開始されました | Atlantic Equities | Overweight |
| 2020-12-15 | アップグレード | Goldman | Sell → Neutral |
| 2020-12-15 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2020-10-08 | アップグレード | Bernstein | Mkt Perform → Outperform |
| 2020-10-08 | アップグレード | Stifel | Hold → Buy |
| 2020-09-11 | 開始されました | Wolfe Research | Peer Perform |
| 2020-05-14 | ダウングレード | DZ Bank | Buy → Hold |
| 2020-03-30 | ダウングレード | Needham | Strong Buy → Buy |
| 2020-03-25 | アップグレード | DZ Bank | Hold → Buy |
| 2020-03-05 | 開始されました | Citigroup | Buy |
| 2020-02-13 | 開始されました | Goldman | Sell |
| 2020-01-08 | 開始されました | SunTrust | Buy |
| 2020-01-02 | アップグレード | Guggenheim | Neutral → Buy |
| 2019-06-05 | アップグレード | Wells Fargo | Market Perform → Outperform |
| 2019-02-04 | 繰り返されました | Needham | Strong Buy |
| 2019-01-03 | 開始されました | Deutsche Bank | Buy |
| 2019-01-02 | ダウングレード | Citigroup | Buy → Neutral |
| 2018-12-19 | アップグレード | JP Morgan | Neutral → Overweight |
| 2018-11-28 | 開始されました | UBS | Buy |
| 2018-10-16 | 開始されました | Barclays | Overweight |
| 2018-08-27 | 繰り返されました | Argus | Buy |
すべてを表示
Medtronic Plc (MDT) 最新ニュース
Medtronic’s Expansion Gains Momentum—Time for a Market Shift? - MarketBeat
$3.77 Bn Surgical Meshes Market Opportunities and Strategies to 2034: Medtronic Leads the Fragmented Market, Followed by Boston Scientific and Johnson & Johnson - Yahoo Finance UK
U.S. Home Healthcare Market Booming with Increasing Adoption | Growth, Innovations & Share: 3M Healthcare, - EIN News
Surgical Sutures Market to Reach $8.8 billion, by 2032 at 6.8% CAGR: Allied Market Research - GlobeNewswire Inc.
Dental Suture Market Detailed In New Research Report 2025 | Medtronic Plc., Sutumed Corp., Katsan Medical Devices - openPR
Medtronic Offers Attractive Entry Point After Q3 Results, RBC Says -February 19, 2025 at 12:32 pm EST - Marketscreener.com
UBS raises Medtronic price target to $95, maintains Neutral rating By Investing.com - Investing.com UK
Stifel maintains Hold on Medtronic stock, price target at $87 - Investing.com India
Medtronic plc (NYSE:MDT) Q3 2025 Earnings Call Transcript - MSN
Cardiac Pacemaker Market Size, Trends & Growth Forecast 2024-2031 | Medtronic Plc., St. Jude Medical, Biotronik. - openPR
Medtronic PLC (MDT) Q3 2025 Earnings Call Highlights: Strong Growth in Cardiac and ... By GuruFocus - Investing.com Canada
Medtronic expects pressure in surgical unit for fourth quarter, shares fall - MSN
Medtronic PLC (MDT) Q3 2025 Earnings Call Highlights: Strong Growth in Cardiac and ... - Yahoo Finance
Medtronic stock holds as Raymond James maintains rating By Investing.com - Investing.com Nigeria
Medtronic Q3 Fiscal 2025 Financial Overview - TipRanks
Medtronic Logs Worst Day In Nearly 5 Years On Q3 Revenue Miss, But Retail Goes Bargain Hunting - MSN
Medtronic’s stock drops on inventory hiccup and revenue miss - MSN
MDT: 3 Healthcare IT Stocks Revolutionizing Patient Care - StockNews.com
Medtronic Earnings Review: Stuck In The Single Digits Again (NYSE:MDT) - Seeking Alpha
Why Medtronic Just Undercut Its Buy Zone With A 7% Drop - Yahoo
Medtronic slips after reaffirming full-year guidance - MSN
Medtronic Earnings: Softer Revenue Growth, but Tight Spending Control Supports Profits - Morningstar
Medtronic Misses Third-Quarter Revenue Views as Some Distributors Lower Inventory Levels - Marketscreener.com
Why Medtronic Just Undercut Its Buy Zone With A 5% Drop - MSN
Medtronic Sinks on Sales Miss – What Went Wrong? - Wall Street Pit
Medtronic nears FDA submission for Hugo robot - MedTech Dive
Top Midday Stories: Medtronic Shares Tumble on Revenue Miss; CNBC's Faber Reportedly Says Walgreens-Sycamore Deal Talks 'Now Alive' - Marketscreener.com
Medtronic's diabetes device sales drive profit beat but surgical unit lags -February 18, 2025 at 10:21 am EST - Marketscreener.com
Earnings call transcript: Medtronic Q3 2025 beats EPS estimates, stock dips - Investing.com
Medtronic's diabetes device sales drive profit beat but surgical unit lags By Reuters - Investing.com
Medtronic Q3 Earnings: Cardiovascular And Neuroscience Drive Growth, Surgical Revenue Dips, Reaffirms Annual Forecast - Benzinga
MDT Earnings: Medtronic Diabetes and Heart Devices Drive Beat - Markets Insider
Medtronic Q3 Earnings Top Estimates, Revenues Miss, Stock Tumbles - Yahoo Finance Australia
Medtronic's diabetes device sales drive profit beat but surgical unit lags - MSN
Medtronic's diabetes device sales drive profit beat but surgical unit lags -February 18, 2025 at 07:07 am EST - Marketscreener.com
Medtronic Q3 earnings beat estimates, revenue misses - MSN
Medtronic PLC Reports Q3 FY25 Earnings: GAAP EPS of $1.01 and Re - GuruFocus.com
Medtronic’s diabetes device sales drive profit beat but surgical unit lags - Blue Water Healthy Living
MDT Earnings: Medtronic reports higher Q3 2025 revenue and adj. profit - AlphaStreet
Raymond James Reiterates Market Perform Rating on Medtronic, Inc. (MDT) - StreetInsider.com
Medtronic plc Re-Iterates Earnings Guidance for the Full Year 2025 -February 18, 2025 at 06:47 am EST - Marketscreener.com
Medtronic: EPS up 7% in Q3 -February 18, 2025 at 07:48 am EST - Marketscreener.com
Medtronic stock slips after Q3 revenue miss (MDT:NYSE) - Seeking Alpha
Medtronic: Fiscal Q3 Earnings Snapshot - CTPost
Medtronic beats quarterly profit estimates on strong heart, diabetes device sales - MSN
Medtronic earnings beat by $0.03, revenue fell short of estimates - Investing.com South Africa
Medtronic's Diabetes Device Sales Drive Profit Beat but Surgical Unit Lags - U.S News & World Report Money
Medtronic beats quarterly profit estimates on strong heart, diabetes device sales -February 18, 2025 at 07:07 am EST - Marketscreener.com
Medtronic’s Third Quarter Fiscal 2025 Revenue Surges to $8.29B - The Tokenist
Medtronic Q3 earnings beat estimates, revenue misses By Investing.com - Investing.com Canada
Medtronic Reiterates FY25 OutlookUpdate - Nasdaq
Medtronic Plc (MDT) 財務データ
収益
当期純利益
現金流量
EPS
0.34%
大文字化:
|
ボリューム (24 時間):